Pharmafile Logo
Pharmafocus logo
Advanced Search

WuXi

Showing 10 posts of 10 posts found.

WuXi begins US plant

May 2, 2014
Manufacturing and Production CMO, China, NY, Shanghai, US, WuXi, pharmatech

Contract manufacturing organisation WuXi PharmaTech has begun work on a new facility in Philadelphia’s Navy Yard for the production of …

News
WuXi AppTec's facility

WuXi AppTec hits big time in disposable manufacturing

November 4, 2013
Manufacturing and Production China, WuXi, antibody, bioreactors

News
MedImmune

MedImmune signs China deal

September 11, 2012
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …

News

Contract research news in brief

September 4, 2012
Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …

News

WuXi continues strong growth

August 14, 2012
Manufacturing and Production China, WuXi

Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …

News

Charles River calls a halt to WuXi merger plans

August 4, 2010
Research and Development Charles River Laboratories, WuXi

Charles River Laboratories has terminated its $1.6 billion agreement to acquire Chinese contract research organisation WuXi PharmaTech after an investor …

News

Contract research news in brief

July 13, 2010
Research and Development Charles River Laboratories, ClinTec, ICON, Quintiles, Synexus, Technical Resources International, WuXi

Charles River places its proposal to merge with China’s WuXi PharmaTech in front of its shareholders, while ClinTec and Synexus …

News

WuXi posts buoyant increases in revenue and profit

May 13, 2010
Research and Development CRO, Charles River, Charles River Laboratories, WuXi

China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …

News

Charles River to buy WuXi for $1.6bn

April 27, 2010
Research and Development Charles River, Charles River Laboratories, WuXi, contract research

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …

News

WuXi’s growth slows

March 17, 2010
Research and Development CRO, China, WuXi

WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026